Activation of phosphatidylinositol 3-kinase/AKT/snail signaling pathway contributes to epithelial-mesenchymal transition-induced multi-drug resistance to sorafenib in hepatocellular carcinoma cells
出版年份 2017 全文链接
标题
Activation of phosphatidylinositol 3-kinase/AKT/snail signaling pathway contributes to epithelial-mesenchymal transition-induced multi-drug resistance to sorafenib in hepatocellular carcinoma cells
作者
关键词
Hepatocellular carcinoma, Small interfering RNAs, Vimentin, MAPK signaling cascades, Polymerase chain reaction, Protein expression, Biotechnology, Transcription factors
出版物
PLoS One
Volume 12, Issue 9, Pages e0185088
出版商
Public Library of Science (PLoS)
发表日期
2017-09-22
DOI
10.1371/journal.pone.0185088
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- CXCR2/CXCL5 axis contributes to epithelial–mesenchymal transition of HCC cells through activating PI3K/Akt/GSK-3β/Snail signaling
- (2015) Shao-Lai Zhou et al. CANCER LETTERS
- Potential molecular, cellular and microenvironmental mechanism of sorafenib resistance in hepatocellular carcinoma
- (2015) Jiang Chen et al. CANCER LETTERS
- CSN5 silencing reverses sorafenib resistance of human hepatocellular carcinoma HepG2 cells
- (2015) HAIBO WANG et al. Molecular Medicine Reports
- Bufalin Reverses Resistance to Sorafenib by Inhibiting Akt Activation in Hepatocellular Carcinoma: The Role of Endoplasmic Reticulum Stress
- (2015) Bo Zhai et al. PLoS One
- FXR1 is elevated in colorectal cancer and acts as an oncogene
- (2015) Xin Jin et al. TUMOR BIOLOGY
- Epithelial–mesenchymal transition plays a critical role in drug resistance of hepatocellular carcinoma cells to oxaliplatin
- (2015) Jun li Ma et al. TUMOR BIOLOGY
- MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway
- (2015) Changjun He et al. Oncotarget
- Inhibition of P-glycoprotein Gene Expression and Function Enhances Triptolide-induced Hepatotoxicity in Mice
- (2015) Ling-Lei Kong et al. Scientific Reports
- A Critical Dose of Doxorubicin Is Required to Alter the Gene Expression Profiles in MCF-7 Cells Acquiring Multidrug Resistance
- (2015) Shang-Hsun Tsou et al. PLoS One
- Epithelial to Mesenchymal Transition is Associated with Shorter Disease-Free Survival in Hepatocellular Carcinoma
- (2014) Suguru Yamada et al. ANNALS OF SURGICAL ONCOLOGY
- Multi-drug resistance in cancer chemotherapeutics: Mechanisms and lab approaches
- (2014) Qiong Wu et al. CANCER LETTERS
- Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells
- (2014) Dali Zhao et al. CELLULAR SIGNALLING
- Down-regulation of Gli-1 inhibits hepatocellular carcinoma cell migration and invasion
- (2014) Jing-Song Chen et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Inhibition of Akt Reverses the Acquired Resistance to Sorafenib by Switching Protective Autophagy to Autophagic Cell Death in Hepatocellular Carcinoma
- (2014) B. Zhai et al. MOLECULAR CANCER THERAPEUTICS
- Snail Promotes Epithelial Mesenchymal Transition in Breast Cancer Cells in Part via Activation of Nuclear ERK2
- (2014) Bethany N. Smith et al. PLoS One
- Arsenic trioxide potentiates the anti-cancer activities of sorafenib against hepatocellular carcinoma by inhibiting Akt activation
- (2014) Bo Zhai et al. TUMOR BIOLOGY
- Epithelial-to-mesenchymal transition: What is the impact on breast cancer stem cells and drug resistance
- (2013) Paraskevi Mallini et al. CANCER TREATMENT REVIEWS
- Crosstalk between Beta-Catenin and Snail in the Induction of Epithelial to Mesenchymal Transition in Hepatocarcinoma: Role of the ERK1/2 Pathway
- (2013) Nathalie Zucchini-Pascal et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Enhanced Metastatic Potential of Hepatocellular Carcinoma (HCC) Cells with Sorafenib Resistance
- (2013) Ariel Ka-Man Chow et al. PLoS One
- Circulating specific biomarkers in diagnosis of hepatocellular carcinoma and its metastasis monitoring
- (2013) Li Wang et al. TUMOR BIOLOGY
- FUT family mediates the multidrug resistance of human hepatocellular carcinoma via the PI3K/Akt signaling pathway
- (2013) L Cheng et al. Cell Death & Disease
- Long-term exposure to sorafenib of liver cancer cells induces resistance with epithelial-to-mesenchymal transition, increased invasion and risk of rebound growth
- (2012) Hannah van Malenstein et al. CANCER LETTERS
- Epithelial mesenchymal transition and hedgehog signaling activation are associated with chemoresistance and invasion of hepatoma subpopulations
- (2011) Xiaoli Chen et al. JOURNAL OF HEPATOLOGY
- Activation of Phosphatidylinositol 3-Kinase/Akt Signaling Pathway Mediates Acquired Resistance to Sorafenib in Hepatocellular Carcinoma Cells
- (2011) K.-F. Chen et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Sorafenib Inhibits the Hepatocyte Growth Factor-Mediated Epithelial Mesenchymal Transition in Hepatocellular Carcinoma
- (2011) T. Nagai et al. MOLECULAR CANCER THERAPEUTICS
- The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation
- (2011) Michelle C. Mendoza et al. TRENDS IN BIOCHEMICAL SCIENCES
- Transcription factors that mediate epithelial–mesenchymal transition lead to multidrug resistance by upregulating ABC transporters
- (2011) M Saxena et al. Cell Death & Disease
- Epithelial-mesenchymal transitions and hepatocarcinogenesis
- (2010) Janice Jou et al. JOURNAL OF CLINICAL INVESTIGATION
- Expression of multidrug resistance-associated protein 1 in hepatocellular carcinoma is associated with a more aggressive tumour phenotype and may reflect a progenitor cell origin
- (2010) Sara Vander Borght et al. LIVER INTERNATIONAL
- Epithelial-Mesenchymal Transitions in Development and Disease
- (2009) Jean Paul Thiery et al. CELL
- Twist1-Mediated Adriamycin-Induced Epithelial-Mesenchymal Transition Relates to Multidrug Resistance and Invasive Potential in Breast Cancer Cells
- (2009) Q.-Q. Li et al. CLINICAL CANCER RESEARCH
- The mTOR pathway is associated with the poor prognosis of human hepatocellular carcinoma
- (2009) Ledu Zhou et al. MEDICAL ONCOLOGY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now